Table 3.
Baseline laboratory results and treatments of the studied 125 patients
|
mean ± SD/n (%)
|
Pulse rate | 92 ± 17 |
Temperature | 37 ± 1 |
Respiratory rate | 23 ± 5 |
Oxygen saturation | 93 ± 5 |
Hemoglobin (gm/dL) | 12 ± 2 |
Platelet count (× 1000/cmm) | 183 ± 107 |
Total leucocyte count (× 1000/cmm) | 10 ± 8 |
Neutrophil : Lymphocyte ratio | 1 ± 0 |
INR | 1.16 ± 0.29 |
PTT | 33.9 ± 13.2 |
Serum creatinine (mg/dL) | 1.39 ± 1.43 |
Serum sodium (mEq/L) | 137 ± 9 |
Serum potassium (mEq/L) | 4.18 ± 0.77 |
Total bilirubin (mg/dL) | 3 ± 5 |
Direct bilirubin (mg/dL) | 2.1 ± 3.8 |
Serum albumin (g/dL) | 3.2 ± 0.7 |
Alanine Transaminase (U/L) | 58 ± 53 |
Aspartate Transaminase (U/L) | 92 ± 123 |
Alkaline phosphatase (U/L) | 262 ± 226 |
Serum ferritin (ng/mL) | 667 ± 483 |
D-dimer (mg/mL) | 1560 ± 2503 |
Fibrinogen (mg/dL) × 100 if presented in g/L | 77 |
Azithromycin | 72 (57.6) |
Paracetamol | 45 (36.0) |
Supplementary vitamin C | 85 (68.0) |
Zinc | 69 (55.2) |
Colchicine | 2 (1.6) |
Lactoferrin | 18 (14.4) |
Other antibiotics | 71 (56.8) |
Steroids | 38 (30.4) |
Hydroxyl-chloroquine | 29 (23.2) |
Low-molecular weight heparin | 56 (44.8) |
Warfarin | 3 (2.4) |
PTT: Partial thromboplastin time; INR: International normalized ratio.